A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice
about
Remarkable role of indoleamine 2,3-dioxygenase and tryptophan metabolites in infectious diseases: potential role in macrophage-mediated inflammatory diseasesIFN-gamma-dependent regulatory circuits in immune inflammation highlighted in diabetes.Decreased IDO activity and increased TTS expression break immune tolerance in patients with immune thrombocytopenia.The immune system strikes back: cellular immune responses against indoleamine 2,3-dioxygenase.The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes.Dendritic cells transduced to express interleukin 4 reduce diabetes onset in both normoglycemic and prediabetic nonobese diabetic miceMechanism underlying defective interferon gamma-induced IDO expression in non-obese diabetic mouse fibroblastsForced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetesTherapy of experimental type 1 diabetes by isolated Sertoli cell xenografts alone.Induction of indoleamine 2, 3-dioxygenase in human dendritic cells by a cholera toxin B subunit-proinsulin vaccine.Myeloid differentiation primary response protein 88 blockade upregulates indoleamine 2,3-dioxygenase expression in rheumatoid synovial fibroblasts.Proteasomal Degradation of Indoleamine 2,3-Dioxygenase in CD8 Dendritic Cells is Mediated by Suppressor of Cytokine Signaling 3 (SOCS3)HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cellsIndoleamine 2,3-Dioxygenase Is Involved in the Inflammation Response of Corneal Epithelial Cells to Aspergillus fumigatus InfectionsUpregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infectionExpression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.Stem cells from human amniotic fluid exert immunoregulatory function via secreted indoleamine 2,3-dioxygenase1.Fibroblast Cell-Based Therapy for Experimental Autoimmune Diabetes.Exogenous tumour necrosis factor alpha induces suppression of autoimmune arthritisRegulatory T cells and autoimmune disease.Indoleamine 2,3-dioxygenase (IDO): the antagonist of type I interferon-driven skin inflammation?Elevated anthranilic acid plasma concentrations in type 1 but not type 2 diabetes mellitusCTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice.STAT3: a potential therapeutic target in dendritic cells for the induction of transplant tolerance.Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells.IFN-gamma-induced IDO and WRS expression in microglia is differentially regulated by IL-4.Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity.IDO activates regulatory T cells and blocks their conversion into Th17-like T cells.Regulation of autoimmune inflammation by pro-inflammatory cytokinesSignaling defects in anti-tumor T cellsProtection against type 1 diabetes upon Coxsackievirus B4 infection and iNKT-cell stimulation: role of suppressive macrophages.IDO: a double-edged sword for T(H)1/T(H)2 regulation.The immunoregulatory enzyme IDO paradoxically drives B cell-mediated autoimmunity.Targeting the immunoregulatory indoleamine 2,3 dioxygenase pathway in immunotherapy.Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1.Different partners, opposite outcomes: a new perspective of the immunobiology of indoleamine 2,3-dioxygenase.Indoleamine 2,3-dioxygenase: from catalyst to signaling function.The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes.Integrated stress response-altered pro-inflammatory signals in mucosal immune-related cells.Advances in our understanding of the pathophysiology of Type 1 diabetes: lessons from the NOD mouse.
P2860
Q21285076-28DB30D2-4401-4EA1-9A51-8F5BB74C27A4Q33382323-C4571E2D-6B6D-4606-A9D4-0B043A66BA38Q33394889-BABC4AC8-B8C1-4925-9A45-CA1B901BC85DQ33501195-19409DA0-C038-4183-B5A0-CCC5BE1EC3BFQ33559343-03DF449C-9019-4E30-8557-52EDB591398AQ33649618-A8C524C2-9131-4A16-9763-B52FD6B7F64CQ34291222-94059266-5515-45B9-A507-25B1E8FF4A90Q34323684-41254A18-7131-4347-87CD-70E93262F05AQ34612686-C55BF1E5-279F-4B4A-BB0E-4AF1EF7F3C90Q35122841-FF5CABD5-32AA-497B-B732-6BBE24F11FAFQ35216385-507360B0-4729-46C8-A8B8-AFB6A901ADEDQ35366959-91105739-29E8-4F6B-8315-69B0EE9DE253Q35751070-215CAB7B-07AB-4C05-B438-7581626D166BQ35770936-9C2A065E-5745-4A26-B4F8-BA991F9CB4CCQ35785085-1028CE48-3EA4-4202-A4C6-93E5EE360F93Q35835489-3B35CEC9-893E-479A-9C39-A3A1B67D7481Q35879522-D046C701-182E-4B98-8213-E500FC9F4F9AQ35893795-A60CE820-5C6B-4A5A-A3C5-BD6E91A5BC89Q36067286-BDFA5762-5659-48FC-A3AF-40F40C7FE3CAQ36079905-1EFD5763-4DA5-48B3-B8E1-1E8D8ACA830DQ36202875-E2F4A66C-2A29-40FE-B48F-D1EB26A3B4FBQ36218874-2663C5EB-EB7F-4F94-A104-A331E8116D3BQ36399304-A64CDA33-45E9-4542-AACF-E4375EF0DBFFQ36481079-F9E577F7-7E4C-463B-A7DB-EDCE288D7766Q36482311-4DCDDC6D-663B-45BB-BE9F-0D71542C85FBQ36793974-C83AFD2A-342B-42BA-96D4-88E38A68BA9AQ36821053-A49FEFB4-F4C1-4288-A1B0-297E4543493CQ36914732-167DD17B-8B2B-410F-A18E-D4765F8B2AC7Q36958814-440B830C-6356-4620-8B0B-B45D289BC340Q37063739-28382ACE-7C32-4F7D-9941-025BCDDE2692Q37251100-D6E04F06-3EE1-457A-AA36-DA9BE9324022Q37281950-DA376AF7-C4CF-4EB7-AE5E-EB1BFF86B6CEQ37340475-7026CE6F-1624-4A2C-8E39-4BBF97262B42Q37352554-BF0C68EB-E1E7-4C82-B014-EA8D9C940404Q37539824-7363500F-985D-4055-8ADA-44A24277400CQ38000471-A7C5461A-1E46-4D64-A5F5-C06566E34A35Q38032201-5CC7A4DC-9858-427C-8CC4-B30AFF747FA4Q38033144-D7BFCFAF-9215-4552-BC28-30F2A59D5A11Q38067151-9DFB706D-1854-40E9-896E-0C058E985E58Q38135862-CCFD0A59-F10A-442C-B715-3B44663A31E4
P2860
A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice
@ast
A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice
@en
type
label
A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice
@ast
A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice
@en
prefLabel
A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice
@ast
A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice
@en
P2093
P2860
P50
P356
P1476
A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice
@en
P2093
Carmine Vacca
Maria C Fioretti
Ursula Grohmann
P2860
P304
P356
10.1084/JEM.20030633
P407
P577
2003-06-30T00:00:00Z